Search the Newsreel

Adelante Capital Management LLC Acquires 7,271 Shares of AvalonBay Communities, Inc. $AVB

Adelante Capital Management LLC increased its stake in AvalonBay Communities (NYSE:AVB) by 2.3% in the first quarter, purchasing 7,271 additional shares and bringing its total holdings to 325,177 shares valued at $53.1 million. The real estate investment trust currently holds a consensus "Hold" rating …

Avalo Therapeutics Inc (AVTX) Institutional Confidence

Avalo Therapeutics Inc (AVTX) has an institutional shareholding score of 5.00, placing it 132nd out of 385 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 60.06%, a 20.42% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 3.72% of …

Empyrean Capital Partners LP Buys Shares of 58,000 AvalonBay Communities, Inc. $AVB

Empyrean Capital Partners LP has acquired a new stake of 58,000 shares in AvalonBay Communities, Inc. (NYSE:AVB) during the first quarter, valued at approximately $9.47 million. Other institutional investors also increased their holdings in the real estate investment trust. Despite these purchases, AVB stock …

Exome Asset Management LLC Makes New $2.38 Million Investment in Avalo Therapeutics, Inc. $AVTX

Avalon Technologies Schedules Q1 Earnings Call on August 5 at 3:30 PM IST

Avalo Therapeutics Inc (AVTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Avalo Therapeutics Inc (AVTX) stock information, focusing on its dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years and lists several merger-related stock splits that occurred …

BlackRock Inc. (AVTX) discloses 6.5% Avalo Therapeutics stake on Schedule 13G

BlackRock, Inc. has disclosed a passive ownership stake of 6.5% in Avalo Therapeutics Inc. common stock, as reported in a Schedule 13G filing. This amounts to 3,415,731 beneficially owned shares, with BlackRock retaining sole voting power over 3,371,733 shares and sole dispositive power over …

Avalo Therapeutics Inc (AVTX) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Avalo Therapeutics Inc (AVTX), noting its current valuation score of 6.96, which ranks 268 out of 386 in the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -3.50, which is significantly below …

First Trust Advisors LP Has $48.75 Million Stock Holdings in AvalonBay Communities, Inc. $AVB

First Trust Advisors LP increased its stake in AvalonBay Communities, Inc. (NYSE:AVB) by 6.4% in the first quarter, bringing its total holdings to $48.75 million. Other institutional investors have also made changes to their positions, with overall institutional ownership at 92.61%. Analysts have a …

Carronade Capital Management LP Reduces Stock Holdings in AvalonBay Communities, Inc. $AVB

Carronade Capital Management LP decreased its stake in AvalonBay Communities Inc. (AVB) by 21.3% in the first quarter, selling 11,148 shares and retaining 41,180 shares valued at $6.7 million. Despite this reduction, institutional ownership remains high at 92.61%, with other major investors such as …

Orbimed Advisors LLC Has $7.09 Million Stock Position in Avalo Therapeutics, Inc. $AVTX

AvalonBay Communities, Inc. (NYSE:AVB) Receives Consensus Rating of "Hold" from Analysts

AvalonBay Communities (NYSE:AVB) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $196.80. The real estate investment trust recently reported Q2 EPS of $1.11, missing estimates, but revenue exceeded expectations at $777.77 million. The company also declared a …

Avalo Therapeutics Inc Revenue Breakdown – TRADEGATE:C6K0

Avalo Therapeutics Inc (C6K0) generated 50.23K EUR in revenue last year, primarily from its Pharmaceutical segment, which is a decrease from 426.00K EUR the previous year. All reported revenue for the company came from the United States. The company's financial performance shows a significant …

AvalonBay Communities (AVB) Q4 2023 Earnings Report - Results, Call & Slides

AvalonBay Communities, Inc. $AVB Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio reduced its stake in AvalonBay Communities (NYSE:AVB) by 12.9% in the first quarter, though it still holds over 211,000 shares valued at approximately $34.6 million. The real estate investment trust reported mixed Q1 results, with earnings per share …

AVB4492279 Bond Profile — Key Metrics

This article provides a detailed profile of the AVB4492279 bond issued by AvalonBay Communities, Inc. Key metrics such as issue date, maturity date, outstanding amount, face value, and coupon rate are highlighted. It also includes a brief description of AvalonBay Communities, Inc., which is …

AVTX|Avalo Therapeutics Inc|Price:18.210|Chg%:+0.450

Avalo Therapeutics Inc. (AVTX) is a clinical-stage biotechnology company focusing on immune dysregulation, with its lead asset AVTX-009 targeting inflammatory diseases like hidradenitis suppurativa. The company exhibits stable fundamentals, high growth potential, and is considered fairly valued by analysts, with a strong buy rating …

Cantor Fitzgerald reiterates Avalo Therapeutics stock rating

Cantor Fitzgerald has reiterated an Overweight rating on Avalo Therapeutics (NASDAQ:AVTX), with the stock having surged 168% over the past year. The firm's analysis focused on Avalo's abdakibart (IL-1b) Phase 2 data and the upcoming Phase 3 trial for hidradenitis suppurativa, alongside implications from …

AvalonBay Communities, Inc. Revenue Breakdown – NYSE:AVB

This article provides a revenue breakdown for AvalonBay Communities, Inc. (NYSE: AVB). In the last year, the company generated $3.05 billion USD, with the "Same Store" segment contributing the most at $2.74 billion USD. The United States was the primary geographic contributor, accounting for …

Why Valor Gold Corp. stock plummeted yesterday

AvalonBay, Equity Residential beat FFO estimates in Q2

AvalonBay (AVB) and Equity Residential (EQR) both surpassed Funds From Operations (FFO) estimates in Q2, indicating strength in the multifamily market, particularly in San Francisco and New York City. Both companies have raised their full-year guidance, driven by improving rents and lower operating expenses. …

Tranche Update on AvalonBay Communities, Inc.'s Equity Buyback Plan announced on February 27, 2026.

AvalonBay Communities, Inc. has provided an update on its equity buyback plan, originally announced on February 27, 2026. The company has repurchased 0 shares worth $0 million between April 1, 2026, and July 23, 2026. Cumulatively, AvalonBay has repurchased 492,378 shares, representing 0.35% of …

AvalonBay Q2 FFO Beats Estimates on Same-Store Gains, '26 Views Raised

AvalonBay Communities, Inc. (AVB) reported strong second-quarter 2026 core FFO per share of $2.86, surpassing analyst estimates, driven by favorable same-store residential revenue and expense results. The company also raised its full-year 2026 same-store outlook for residential revenue growth and NOI growth, while their …

AvalonBay (NYSE: AVB) Q2 results, guidance shift amid EQR merger

AvalonBay Communities reported Q2 2026 results including diluted EPS of $1.11, FFO per share of $2.73, and Core FFO per share of $2.86, with Same Store Residential revenue increasing by 1.6%. The company has suspended its EPS, FFO, and Core FFO outlook due to …

Lasalle Investment Management Securities LLC Has $56.32 Million Stake in AvalonBay Communities, Inc. $AVB

Lasalle Investment Management Securities LLC increased its stake in AvalonBay Communities, Inc. (AVB) by 3.6% in the first quarter, now holding 344,766 shares valued at $56.32 million. AvalonBay reported better-than-expected Q2 EPS of $2.86, though revenue missed estimates, and its dividend payout ratio is …

KBC Group NV Trims Stock Position in AvalonBay Communities, Inc. $AVB

KBC Group NV has reduced its stake in AvalonBay Communities, Inc. (NYSE:AVB) by 26.4% in the first quarter, selling 14,201 shares and now holding 39,535 shares valued at approximately $6.46 million. Despite this, AvalonBay reported strong quarterly earnings of $2.86 per share, significantly exceeding …

AvalonBay Communities BDRs undergo 4-for-1 stock split in Brazil ratio adjustment

AvalonBay Communities is implementing a mandatory 4-for-1 stock split for its Brazilian Depositary Receipts (BDRs), effective August 24, 2026. This adjustment changes the BDR-to-underlying ratio from 1:4 to 1:16, with holders receiving three additional BDRs for each one held. Fractional entitlements will be settled …

AvalonBay (AVB) Reports Q2 Earnings: What Key Metrics Have to Say

AvalonBay Communities (AVB) reported Q2 2026 earnings, with revenues of $777.77 million, a 2.3% increase year-over-year, and EPS of $2.86. Both revenue and EPS surpassed Zacks Consensus Estimates. Key metrics like Same Store Economic Occupancy and Revenue-Rental and other income also performed well, indicating …

AvalonBay Communities (AVB) Beats Q2 FFO and Revenue Estimates

AvalonBay Communities (AVB) reported Q2 FFO of $2.86 per share, surpassing the Zacks Consensus Estimate of $2.8 per share, and revenues of $777.77 million, beating estimates by 0.31%. Despite outperforming FFO estimates in three of the last four quarters, the stock has underperformed the …

Earnings Flash (AVB) AvalonBay Communities Posts Q2 Core FFO $2.86, vs. FactSet Est. of $2.81

AvalonBay Communities (AVB) announced its Q2 Core FFO of $2.86, exceeding the FactSet estimated $2.81. This news comes amidst several analyst adjustments to price targets for the residential REIT, with ratings ranging from Neutral to Buy, and one downgrade to Equalweight. The company also …

Form 4 AvalonBay Communities Inc For: 22 July By Investing.com

This article from Investing.com is a terse notification about a Form 4 filing related to AvalonBay Communities Inc. for July 22. It provides no further details beyond the title and company name, typical of automated financial news alerts about regulatory filings. The article primarily …

Equity Residential and AvalonBay (NYSE: AVB) detail Q2 results and $71B merger plan

Equity Residential reported mixed Q2 2026 results with EPS down but Normalized FFO per share and same-store NOI up. The company raised its full-year 2026 guidance for same-store NOI growth and announced the sale of two properties and the completion of two development projects. …

AvalonBay Communities (NYSE: AVB) outlines $71B all-stock merger and Q2 2026 FFO gains

AvalonBay Communities (AVB) and Equity Residential plan a $71 billion all-stock merger, creating a significant rental housing platform with 634 communities and 184,000 apartment homes. The merger is expected to generate $175 million in gross cost synergies and an initial annualized dividend of $2.81 …

Proposed Equity Residential-AvalonBay merger: more than 180,000 apartments

Equity Residential (NYSE: EQR) reported its Q2 2026 results, showing increased same-store revenues and net operating income (NOI), and raised its full-year operating guidance. The company also provided updates on its pending all-stock merger with AvalonBay Communities, Inc. (NYSE: AVB), which is expected to …

AvalonBay Communities, Inc. Provides Q2 2026 Results, Increases Same Store Outlook, and Suspends EPS, FFO, and Core FFO Outlook Due to Proposed Merger

AvalonBay Communities, Inc. reported strong Q2 2026 results, exceeding expectations, with EPS at $1.11, FFO per share at $2.73, and Core FFO per share at $2.86. The company increased its full-year Same Store NOI guidance due to a healthy demand environment and easing new …

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference

Avalo Therapeutics, a clinical-stage biotechnology company, announced that its CEO, Dr. Garry Neil, will participate in a panel discussion at the virtual BTIG Biotechnology Conference on July 29, 2026. Management will also hold one-on-one investor meetings. The company is focused on developing therapeutics targeting …